Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

A KLF4-DYRK2-mediated pathway regulating self-renewal in CML stem cells.

Park CS, Lewis AH, Chen TJ, Bridges CS, Shen Y, Suppipat K, Puppi M, Tomolonis JA, Pang PD, Mistretta TA, Ma L, Green MR, Rau R, Lacorazza HD.

Blood. 2019 Nov 28;134(22):1960-1972. doi: 10.1182/blood.2018875922.

PMID:
31515251
2.

Neuroblastoma pathogenesis: deregulation of embryonic neural crest development.

Tomolonis JA, Agarwal S, Shohet JM.

Cell Tissue Res. 2018 May;372(2):245-262. doi: 10.1007/s00441-017-2747-0. Epub 2017 Dec 8. Review.

3.

Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia.

Pankowicz FP, Barzi M, Legras X, Hubert L, Mi T, Tomolonis JA, Ravishankar M, Sun Q, Yang D, Borowiak M, Sumazin P, Elsea SH, Bissig-Choisat B, Bissig KD.

Nat Commun. 2016 Aug 30;7:12642. doi: 10.1038/ncomms12642.

4.

A Broad-Spectrum Infection Diagnostic that Detects Pathogen-Associated Molecular Patterns (PAMPs) in Whole Blood.

Cartwright M, Rottman M, Shapiro NI, Seiler B, Lombardo P, Gamini N, Tomolonis J, Watters AL, Waterhouse A, Leslie D, Bolgen D, Graveline A, Kang JH, Didar T, Dimitrakakis N, Cartwright D, Super M, Ingber DE.

EBioMedicine. 2016 Jul;9:217-227. doi: 10.1016/j.ebiom.2016.06.014. Epub 2016 Jun 13.

5.

Non-muscle myosin-IIA is critical for podocyte f-actin organization, contractility, and attenuation of cell motility.

Bondzie PA, Chen HA, Cao MZ, Tomolonis JA, He F, Pollak MR, Henderson JM.

Cytoskeleton (Hoboken). 2016 Aug;73(8):377-95. doi: 10.1002/cm.21313. Epub 2016 Jul 21.

PMID:
27232264

Supplemental Content

Loading ...
Support Center